MVA.HPV16/18

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMVA.HPV16/18
Drug Alias NameMVA-BN HPVJNJ-65195208
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A